Ariosa, Illumina Resolve DNA Patent Dispute At High Court

By Dani Kass (May 24, 2021, 4:54 PM EDT) -- While the U.S. Supreme Court was deciding whether to take up the eligibility of Illumina Inc.'s DNA test patents, the company and Ariosa Diagnostics Inc. resolved the dispute and took it off the justices' docket.

The justices were reviewing Ariosa's petition at their Friday conference, when the company filed a joint stipulation asking for the petition to be dismissed. The court did so the same day.

"All parties respectfully submit that this case be dismissed," the joint stipulation states. "All fees due to the clerk have been paid, and each party will bear its own costs."

Counsel for Illumina, Ariosa and the latter's...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!